ijms-logo

Journal Browser

Journal Browser

Progress and Future Directions on Physical Activity and Skeletal Muscle Research in Chronic Kidney Disease

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (20 August 2024) | Viewed by 3709

Special Issue Editor


E-Mail Website
Guest Editor
Faculty of Physiotherapy, Wroclaw University of Health and Sport Sciences, 51-612 Wroclaw, Poland
Interests: skeletal muscle; physical activity; exercise; endurance training; resistance training; CKD patients; hemodialysis patients; healthy aging; frailty

Special Issue Information

Dear Colleagues,

Chronic kidney disease (CKD) is associated with a high risk of morbidity and mortality, and presents a significant public health concern, with increasing incidence and prevalence. With progression to end-stage renal disease (ESRD), patients are directed to kidney replacement therapy (KRT). CKD patients often report fatigue, muscle weakness, and pain. Reductions in muscle strength and related levels of physical capacity are observed already in the early stages of the disease. The mechanism of these changes can be primary, caused by myopathy or uremic sarcopenia, as well as secondary, as a result of several factors: comorbidities, lifestyle, and age-related sarcopenia and frailty. These factors strongly impair patients’ levels of physical activity, daily functioning, and quality of life, leading to an excessively sedentary lifestyle and increased CVD risk. Thus, it is very important to understand these pathological mechanisms and to establish significant interventions regarding the improvement of physical function and reduction of risk factors.

We would love to invite you to submit original research articles and reviews that focus on, but are not limited to, innovative and important findings that provide a comprehensive molecular mechanism for physical activity and skeletal muscle research in chronic kidney disease.

Dr. Wioletta Dziubek
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • skeletal muscle
  • exercise
  • CKD patients
  • hemodialysis patients
  • inflammation
  • cytokines
  • frailty
  • uremic sarcopenia
  • risk of fall

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 2021 KiB  
Review
Pathogenesis of Sarcopenia in Chronic Kidney Disease—The Role of Inflammation, Metabolic Dysregulation, Gut Dysbiosis, and microRNA
by Estera Bakinowska, Joanna Olejnik-Wojciechowska, Kajetan Kiełbowski, Anastasiia Skoryk and Andrzej Pawlik
Int. J. Mol. Sci. 2024, 25(15), 8474; https://doi.org/10.3390/ijms25158474 - 3 Aug 2024
Cited by 7 | Viewed by 3076
Abstract
Chronic kidney disease (CKD) is a progressive disorder associated with a decline in kidney function. Consequently, patients with advanced stages of CKD require renal replacement therapies, such as dialysis and kidney transplantation. Various conditions lead to the development of CKD, including diabetes mellitus, [...] Read more.
Chronic kidney disease (CKD) is a progressive disorder associated with a decline in kidney function. Consequently, patients with advanced stages of CKD require renal replacement therapies, such as dialysis and kidney transplantation. Various conditions lead to the development of CKD, including diabetes mellitus, hypertension, and glomerulonephritis, among others. The disease is associated with metabolic and hormonal dysregulation, including uraemia and hyperparathyroidism, as well as with low-grade systemic inflammation. Altered homeostasis increases the risk of developing severe comorbidities, such as cardiovascular diseases or sarcopenia, which increase mortality. Sarcopenia is defined as a progressive decline in muscle mass and function. However, the precise mechanisms that link CKD and the development of sarcopenia are poorly understood. Knowledge about these linking mechanisms might lead to the introduction of precise treatment strategies that could prevent muscle wasting. This review discusses inflammatory mediators, metabolic and hormonal dysregulation, gut microbiota dysbiosis, and non-coding RNA alterations that could link CKD and sarcopenia. Full article
Show Figures

Figure 1

Back to TopTop